Adamts14 inhibition
US-2024401057-A1 · Dec 5, 2024 · US
This page is not indexed by search engines while we improve data quality.
The General Hospital Corp D/B/A Massachusetts General Hospital — Cross-Sectional Technologies
The General Hospital Corp D/B/A Massachusetts General Hospital holds 9 patents in Cross-Sectional Technologies, with representative filings summarized below.
| Metric | Value |
|---|---|
| Company | The General Hospital Corp D/B/A Massachusetts General Hospital |
| Technology | Cross-Sectional Technologies |
| Patents in slice | 9 |
| Recent patents in slice | 1 |
| First year | 2017 |
| Last year | 2024 |
Representative patents
Notable publications linking The General Hospital Corp D/B/A Massachusetts General Hospital to Cross-Sectional Technologies.
Compositions of microbiota and methods related thereto
US-2020246395-A1 · Aug 6, 2020 · US
Compositions of microbiota and methods related thereto
US-2020237835-A1 · Jul 30, 2020 · US
Compositions of microbiota and methods related thereto
US-2020237835-A1 · Jul 30, 2020 · US
Compositions of microbiota and methods related thereto
US-2020237835-A1 · Jul 30, 2020 · US
Recent filings
Latest patents from The General Hospital Corp D/B/A Massachusetts General Hospital in Cross-Sectional Technologies.
Adamts14 inhibition
US-2024401057-A1 · Dec 5, 2024 · US
Compositions of microbiota and methods related thereto
US-2020246395-A1 · Aug 6, 2020 · US
Compositions of microbiota and methods related thereto
US-2020237835-A1 · Jul 30, 2020 · US
Compositions of microbiota and methods related thereto
US-2020237835-A1 · Jul 30, 2020 · US
Compositions of microbiota and methods related thereto
US-2020237835-A1 · Jul 30, 2020 · US
Related pages
Navigate to parent entity pages.